Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models

Angelo Boffa, Manuela Salerno, Giulia Merli, Laura De Girolamo, Lior Laver, Jérémy Magalon, Mikel Sánchez, Thomas Tischer, Giuseppe Filardo

Research output: Contribution to journalReview articlepeer-review

Abstract

PURPOSE: The mechanisms of action and disease-modifying potential of platelet-rich plasma (PRP) injection for osteoarthritis (OA) treatment are still not fully established. The aim of this systematic review of preclinical evidence was to determine if PRP injections can induce disease-modifying effects in OA joints.

METHODS: A systematic review was performed on animal studies evaluating intra-articular PRP injections as treatment for OA joints. A synthesis of the results was performed investigating the disease-modifying effects of PRP by evaluating studies that compared PRP with OA controls or other injectable products, different PRP formulations or injection intervals, and the combination of PRP with other products. The risk of bias was assessed according to the SYRCLE's tool.

RESULTS: Forty-four articles were included, for a total of 1251 animals. The publication trend remarkably increased over time. PRP injections showed clinical effects in 80% and disease-modifying effects in 68% of the studies, attenuating cartilage damage progression and reducing synovial inflammation, coupled with changes in biomarker levels. Evidence is limited on the best PRP formulation, injection intervals, and synergistic effect with other injectables. The risk of bias was low in 40%, unclear in 56%, and high in 4% of items.

CONCLUSION: Intra-articular PRP injections showed disease-modifying effects in most studies, both at the cartilage and synovial level. These findings in animal OA models can play a crucial role in understanding mechanism of action and structural effects of this biological approach. Nevertheless, the overall low quality of the published studies warrants further preclinical studies to confirm the positive findings, as well as high-level human trials to demonstrate if these results translate into disease-modifying effects when PRP is used in the clinical practice to treat OA.

LEVEL OF EVIDENCE: Level II.

Original languageEnglish
Pages (from-to)4100-4121
Number of pages22
JournalKnee Surgery, Sports Traumatology, Arthroscopy
Volume29
Issue number12
Early online dateAug 2 2021
DOIs
Publication statusPublished - Dec 2021

Keywords

  • Cartilage
  • Disease-modifying
  • Injection
  • Intra-articular
  • Osteoarthritis
  • Platelet-rich plasma (PRP)

Fingerprint

Dive into the research topics of 'Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models'. Together they form a unique fingerprint.

Cite this